Walker, J. A., Miller, A. D., Burdo, T. H., McGrath, M. S., & Williams, K. C. (2017). Direct Targeting of Macrophages with Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology. J Acquir Immune Defic Syndr.
Chicago Style citaatWalker, Joshua A., Andrew D. Miller, Tricia H. Burdo, Michael S. McGrath, en Kenneth C. Williams. "Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology." J Acquir Immune Defic Syndr 2017.
MLA citatieWalker, Joshua A., et al. "Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology." J Acquir Immune Defic Syndr 2017.